Similar articles

• Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.

  Rodt H, Therfelder S, Eulitz M. Rodt H, et al. Exp Hematol. 1974;2(4):195-203. Exp Hematol. 1974. PMID: 4156327 No abstract available.
• Adaptive phenomena in bone marrow transplantation.

  Goujet-Zalc C, Ilbery PL. Goujet-Zalc C, et al. Exp Hematol. 1973;1(1):3-10. Exp Hematol. 1973. PMID: 4154047 Review. No abstract available.
• Bone marrow transplantation in inbred strains of mice. I. The failure of development of normal T cell function following allogeneic transplantation.

  Trier L, Rubin B. Trier L, et al. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974 Oct;82B(5):724-32. Acta Pathol Microbiol Scand B Microbiol Immunol. 1974. PMID: 4139875 No abstract available.
• Anti-human thymocyte globulin (ATG) for prophylaxis and treatment of graft-versus-host disease in recipients of allogeneic marrow grafts.

  Weiden PL, Doney K, Storb R, Thomas ED. Weiden PL, et al. Transplant Proc. 1978 Mar;10(1):213-6. Transplant Proc. 1978. PMID: 345561 No abstract available.
• Graft-versus-host disease.

  Gatti RA, Kersey JH, Yunis EJ, Good RA. Gatti RA, et al. Prog Clin Pathol. 1973;5:1-18. Prog Clin Pathol. 1973. PMID: 4150104 Review. No abstract available.